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Abstract 11 
 12 
Caffeine is an increasingly popular nutritional supplement due to the legal, significant 13 
improvements in sporting performance that it has been documented to elicit, with 14 
minimal side effects. Therefore, the effects of caffeine on human performance 15 
continues to be a popular area of research as we strive to improve our understanding 16 
of this drug and make more precise recommendations for its use in sport. Although 17 
variation in exercise intensity seems to affect its ergogenic benefits, it is largely 18 
considered that caffeine can promote significant improvements in endurance, power 19 
and strength based activities. There are a number of limitations to testing caffeine 20 
induced effects on human performance that can be better controlled when testing 21 
isolated muscle under in vitro conditions. The hydrophobic nature of caffeine results 22 
in a post digestion distribution to all tissues of the body making it difficult to 23 
accurately quantify the key mechanism of action. This review considers the 24 
contribution of evidence from isolated muscle studies to our understating of the direct 25 
effects of caffeine on muscle during human performance. The body of in vitro 26 
evidence presented suggests that caffeine can directly potentiate skeletal muscle force, 27 
work and power which may be important contributors to the performance enhancing 28 
effects seen in humans.  29 
 30 
 31 
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 49 
Introduction 50 
 51 
Caffeine is the most commonly consumed drug in the world (Graham, 2001) and its 52 
ability to induce legal improvements in exercise performance has made it an 53 
increasingly popular ergogenic supplement. Mechanistically, the action of caffeine in 54 
the whole body is difficult to pinpoint due to the nature of its wide distribution to 55 
bodily tissues (Magkos & Kavouras, 2005). It is largely considered that caffeine will 56 
act as a central nervous system (CNS) stimulant, however glycogen sparing, increases 57 
in fatty acid mobilization, catecholamine release and direct muscle effects, are also 58 
reported but debatable mechanisms attributing the ergogenic effect (See reviews by 59 
Graham, 2001; Magkos & Kavouras, 2005; Davis & Green, 2009). The usage of in 60 
vitro experiments to apply caffeine to isolated muscle provides an important method 61 
for quantifying the direct effect of caffeine on muscle as a potential mechanism for 62 
improvement in sports performance. A number of more recent publications (James et 63 
al., 2005; Tallis et al., 2012; 2013b) have used advances in methodology to more 64 
accurately examine the direct effect of caffeine on skeletal muscle mechanical 65 
performance and as such have significantly contributed to our understanding of the 66 
caffeine response. The evidence presented indicates that physiological concentrations 67 
of caffeine can directly affect skeletal muscle to cause a significant enhancement in 68 
mechanical performance increasing the ability of the muscle to produce force, work 69 
and power. Such effects could be used in humans to increase training stimulus and to 70 
improve performance in competition.    71 
 72 
Caffeine & Sport Performance 73 
 74 
It is widely accepted that caffeine ingestion can promote performance enhancing 75 
effects on endurance (activity lasting greater than 30 minutes), power and strength 76 
activities, although there is debate regarding the magnitude of effect (Graham et al., 77 
2001). Evidence demonstrates that caffeine has greater potency when used as an acute 78 
supplement in endurance based activities, whilst results from studies using short term 79 
high intensity exercise protocols appear to be a more ambiguous (Graham et al., 2001; 80 
Davis & Green, 2009; Goldstein et al., 2009). The effect of caffeine ingestion on sport 81 
performance has been extensively explored in a number of reviews (Graham et al., 82 
2001; Burke, 2008; Davis & Green, 2009; Goldstein et al., 2009; Astorino and 83 
Roberson, 2010). 84 
 85 
Evidence from these articles suggest that mode and intensity of exercise, caffeine 86 
consumption habits, fitness level, treatment dose and individual differences in 87 
caffeine digestion, distribution and sensitivity could greatly influence the caffeine 88 
induced response in human performance (Fig 1). It is likely that the varied caffeine 89 
response and conflicting evidence demonstrated throughout the literature can largely 90 
be attributed to methodological differences between studies. 91 
 92 
[Insert Figure 1 here] 93 
 94 
In the most part, the previously cited literature reviews suggest that the performance 95 
enhancing effect of caffeine is greater in trained athletes compared to non-trained 96 
athletes (Graham, 2001; Astorino and Roberson, 2010). Although there is a distinct 97 
dearth of studies directly assessing this, Leblanc (1985) demonstrated that trained 98 
individuals had increased resting metabolic rate, adrenaline and free fatty acids 99 
compared to an untrained population. Furthermore, Collomp et al., (1992) reported 100 
faster swim speeds in trained athletes that were not paralleled in an untrained group 101 
following a 250mg caffeine dose. The mechanism responsible for these response 102 
differences is largely unknown, but it is considered that as many experimental 103 
procedures require participants to work maximally, trained individuals will have 104 
greater motivation to perform fatiguing exercise, will have better nutritional 105 
preparation, and the day-to-day performance variation will be reduced (Burke, 2008).  106 
 107 
Furthermore evidence suggests a greater ergogenic benefit in non-habituated 108 
consumers (Bell & McClellan, 2002). Caffeine is rich in the western diet and 109 
recruiting participants that consume similar quantities is near impossible, and in many 110 
studies participants are considered as habitual users (Tarnoposlky & Cupido, 2000; 111 
Bridge & Jones, 2006; Duncan et al., 2014). Although it appears that the effects of 112 
habituation on the magnitude of response needs further investigation (Graham et al., 113 
2001; Astorino et al., 2010), this mechanism is in part attributed to the division of 114 
responders and non-responders to caffeine treatment that has been reported in studies 115 
examining responses on an individual level (Skinner et al.,2009). 116 
 117 
Another methodological debate relates to the withdrawal of caffeine prior to 118 
completion of the experimental trial. It is common practice for researchers to restrict 119 
caffeine consumption 12-48 hours prior to completion of the exercise protocol (Bell & 120 
McLellan, 2002; Glaister et al., 2008; Duncan et al., 2014). Although evidence 121 
indicates that withdrawal has limited effects on exercise performance, there is a 122 
wealth of literature demonstrating negative effects on mood, stress, fatigue, alertness 123 
and short term memory (Smith, 2002). James (1994) suggested that caffeine has no 124 
behavioural effect, but consumption merely removes negative effects associated with 125 
withdrawal.  126 
  127 
Although it is common to administer caffeine per unit body mass, a number of studies 128 
have used absolute doses (Collomp et al., 1992; Kovacs et al., 1998), thus potentially 129 
resulting in erroneous results due to vastly different relative doses between 130 
individuals. It is generally considered that 3mg.kg-1 is the lowest level to elicit 131 
ergogenic benefit on exercise performance (Graham et al., 2001), and it is common 132 
practice to administer caffeine in doses of  5-6 mg.kg-1 (Jackman et al., 1996; Bridge 133 
& Jones, 2006; O’Rouke et al., 2006; Carr et al., 2008).  Despite research assessing a 134 
variety of doses ranging between 0.5-13 mg.kg-1 (Wiles et al., 1992; Pasman et al., 135 
1995; Graham & Spriet, 1991; Bruce et al., 2000; Cohen et al., 2006), only a small 136 
number of studies have examined the dose response relationship on human 137 
performance (Perkins & Williams, 1975; Graham & Spriet, 1995; Cohen et al., 1996; 138 
Kovacs et al., 1998; Bruce et al., 2000; O’Connor et al., 2004). Few of these studies 139 
actually demonstrate an ergogenic benefit of caffeine (Graham & Spriet, 1995; 140 
Kovacs et al., 1998; Bruce et al., 2000; O’Connor et al., 2004), and thus, conclusions 141 
regarding dose dependant effects are based on a limited number of studies. It is 142 
generally considered that an increased caffeine dose fails to elicit a further response; 143 
however contradictory evidence is also presented (Kovacs et al., 1998). It is further 144 
considered that inter-individual side effects related to consumption of high caffeine 145 
concentrations may actually result in decreased performance (Graham & Spriet, 146 
1995). Although there is some ambiguity in a caffeine dose response relationship, 147 
anecdotal evidence suggests caffeine induced dose related relationships in the 148 
reduction in pain perception and increased plasma epinephrine and free fatty acid 149 
concentration (Graham & Spriet, 1995; Pasman et al., 1995; O’Connor et al., 2000), 150 
which may evoke performance enhancing benefits in other modes of exercise. The 151 
variety of methodological approaches and results demonstrated, make meaningful 152 
conclusions and recommendations to athletes difficult to fully quantify. Furthermore, 153 
there is difficulty isolating the direct effect of caffeine from systematic effects due to 154 
the number of potential mechanisms evoked from its wide distribution within the 155 
body.  It is commonly reported that caffeine acts as a central nervous system stimulant 156 
due to its action as an adenosine receptor antagonist (Fredholm et al., 1999). 157 
Additionally, the increased effectiveness of caffeine on endurance based sports has 158 
led to a common misconception that caffeine may increase the utilisation of free fatty 159 
acids as an energy source thus permitting glycogen sparing. The evidence supporting 160 
this claim is inconclusive (Graham; 2001; Davis & Green, 2009). The action of 161 
caffeine to promote increased adrenaline release, evoke greater Ca2+ release from the 162 
sarcoplasmic reticulum, improve the function of the Na+/K+ pump and reduce pain 163 
perception are further mechanisms believed to contribute to caffeine’s performance 164 
enhancing effect (Graham, 2001; Magkos & Kavouras, 2005; Davis & Green, 2009). 165 
Although the effectiveness of caffeine as a performance enhancer is widely reported, 166 
the outlined discrepancies have confounded our ability to make an accurate judgement 167 
on the specific action of caffeine.  168 
 169 
Benefits of Testing the Direct Effect of Caffeine on Isolated Muscle 170 
 171 
Many of the aforementioned variables that limit our ability to fully review results 172 
from whole body, in vivo, testing of the effects of caffeine can be controlled in studies 173 
assessing the direct ergogenic effect of caffeine on isolated skeletal muscle. During 174 
such in vitro studies a target muscle(s) is isolated, usually from a rodent/amphibian, 175 
and placed in an organ bath circulated with oxygenated Krebs-Henseleit/Ringer 176 
solution, which is high in glucose and contains other salts to mimic blood plasma. 177 
Maximal muscle activity is induced by subjecting the muscle to an external electrical 178 
stimulation. A caffeine dose is added directly to the Krebs/Ringer solution, and the 179 
mechanical performance of the muscle is reexamined. Typical assessments include 180 
the measurement of maximal isometric twitch and tetanus force, and associated 181 
activation and relaxation times. During isometric studies the muscle is held at a 182 
constant length and subjected to a single stimulation (twitch) or multiple stimulations 183 
(tetanus) to determine peak force, muscle length is adjusted until maximal force is 184 
achieved (Luttgau & Oetliker, 1968; Allen & Westerblad, 1995; Germinario et al., 185 
2004). More recently, the work-loop technique has been implemented as a method of 186 
assessing the effects of caffeine on muscle power output during the types of dynamic 187 
muscle activity that are more common during in vivo muscle action (James et al., 188 
2004; 2005; Tallis et al., 2012; 2013b; 2014b). 189 
 190 
Evidence suggests that caffeine metabolism and consequently magnitude of the 191 
potential effect may be related to variations in genotype. It has been reported that a 192 
single substitution of a gene can cause individuals to be slow or fast caffeine 193 
metabolisers (Sokmen et al., 2008). Additionally as caffeine is distributed evenly to 194 
all tissues of the body, those with a greater body fat will have a greater adipose tissue 195 
concentration, thus reducing the quantity acting at the tissues that can improve sports 196 
performance. A direct skeletal muscle caffeine treatment avoids the potential 197 
limitations associated with digestion and metabolism, and this method assures that 198 
that the same dose reaches each examined tissues.  199 
In human studies it is difficult to isolate factors that result in a direct muscle 200 
performance improvement from a muscle performance improvement resulting from 201 
central mechanisms. An isolated muscle is externally stimulated and its metabolism 202 
controlled, thus it is possible to exclusively examine the skeletal muscle reaction to a 203 
caffeine dose. Furthermore, lab animals from which the muscle preparations are taken 204 
have a controlled low caffeine diet which reduces the potential issue of habituation 205 
and pre-activity withdrawal effects influencing the results. Implementation of such 206 
methods within this research area uniquely allow the examination of muscle fiber type 207 
specific effects of caffeine treatment, which have been proposed as a mechanistic 208 
rational for the increased potency of caffeine in relation to endurance based events. 209 
Isolated muscle also allows improved analysis of a dose-response relationship, 210 
without the adverse side effects of high caffeine consumption seen during in vivo 211 
work (Graham & Spriet, 1995). The effect of caffeine on exercise mode can be 212 
considered in greater detail in vitro, allowing the investigation of maximal and 213 
submaximal contraction, fatigue and recovery, using both isometric and dynamic 214 
work loop protocols. Such in vitro studies have been, and continue to be, vital to 215 
improving our understanding of the ergogenic effects of caffeine.  216 
 217 
The Effect of mM Concentrations of Caffeine on Skeletal Muscle Contractility 218 
 219 
Much of the evidence demonstrating the direct ergogenic properties of caffeine on 220 
skeletal muscle is derived from early in vitro studies such as Luttgau & Oetliker 221 
(1968) who tested millimolar (mM) caffeine concentrations (supraphysiological for 222 
humans) on isolated semitendinosus and iliofibularis muscle from Rana temporaria. 223 
The study concluded that significant increases in twitch force occurred following 224 
treatment with 6-10 mM caffeine, with an increased sensitivity to caffeine following a 225 
drop in temperature from 20oC to 1-3oC. At high concentrations caffeine has even 226 
been shown to produce contracture without stimulation (Huddart, 1968). A number of 227 
isolated muscle studies have demonstrated the potentiation of muscle force following 228 
a direct treatment with caffeine (Table 1). Furthermore, it is largely accepted that the 229 
ergogenic benefit is more pronounced in slow twitch muscle (Rossi et al. 2001; 230 
Wondmikun et al,. 2006; Tallis et al., 2012), and that a reduction in temperature 231 
increases sensitivity to caffeine (Luttgau & Oetliker, 1968; Weber & Herz, 1968), 232 
particularly in slow twitch muscle (Wondmikun et al., 2006). 233 
 234 
[Insert Table 1 here] 235 
 236 
Mechanistically caffeine will promote greater force output in skeletal muscle due to 237 
modification of excitation contraction coupling (Davis & Green, 2009). Weber & 238 
Herz (1968) was one of the earliest studies to investigate this theory by isolating 239 
sarcoplasmic reticulum (SR) from skeletal muscle of Rana pipiens and monitoring 240 
Ca2+ release to varying millimolar concentrations of caffeine. Caffeine treatment 241 
resulted in an immediate release of Ca2+ in 11 of 12 preparations, attributed to a shift 242 
in the voltage dependant Ca2+ release mechanism to a more negative membrane 243 
potential. This was later confirmed by Endo et al., (1970) using skinned muscle 244 
preparations with SR left intact. More specifically, it is believed that caffeine operates 245 
directly as an adenosine receptor antagonist on A1 receptors on the skeletal muscle 246 
membrane and/or binds to Ryanodine receptors (RYR) of the SR as demonstrated in 247 
vitro with 10mM caffeine treatment and in RYR -/- mice (Damiani et al., 1996; Bhat 248 
et al,. 1997; Fredholm et al., 1999; Rossi et al., 2001). Ultimately this has been shown 249 
to result in a greater release of Ca2+ into the intramuscular space, increased 250 
myofibrillar Ca2+ sensitivity, slowing of the SR Ca2+ pump, and increased SR Ca2+ 251 
permeability, significantly modifying skeletal muscle performance (Allen et al., 1989; 252 
Westerblad & Allen, 1991; Allen & Westerblad, 1995). The consequential decrease in 253 
rate of Ca2+ efflux from the intracellular space, due to the reduced action of the SR 254 
Ca2+ pump, is the mechanism underpinning the commonly reported caffeine induced 255 
increase in isometric relaxation time (Allen et al., 1989; Westerblad & Allen, 1991).  256 
 257 
These studies have proven important in enhancing our understanding of the direct 258 
effect of caffeine on isolated muscle performance; problems arise when attempting to 259 
link the outcomes of this research to human performance. The authors recognise that 260 
although this may not be the primary intention of all of these studies, the underlying 261 
mechanism of response to caffeine in human literature is commonly attributed to such 262 
research.  263 
 264 
A significant limitation in many of these studies is the use of supraphysiological, 265 
millimolar, concentrations of caffeine (Luttgau & Oetliker, 1968; Endo et al., 1970; 266 
Huddart, 1968; Weber & Herz, 1986; Allen & Westerblad, 1995; Rossi et al., 2001; 267 
Germinario et al., 2004) which would be toxic to humans (Fredholm et al., 1999), and 268 
as such these studies have poor relevance to the effects of ingested caffeine on human 269 
performance. Fredholm et al., (1999) reported that blood plasma concentrations 270 
exceeding 1mM would be fatal for humans and common concentrations are usually 271 
between 20-50µM (Graham, 2001), with 70µM being the nontoxic limit (Fredholm et 272 
al., 1999).   273 
 274 
Although it has been demonstrated that caffeine has increased potency at lower 275 
temperatures, most previous studies have used test temperatures that have little 276 
physiological relevance to humans (Ritchie, 1954; Luttgau & Oetliker, 1968; Weber 277 
& Herz, 1986; Fryer & Neering, 1989; Allen & Westerblad, 1995; Rossi et al., 2001; 278 
Germinario et al., 2004; Rosser et al., 2009).  Lower test temperatures are usually 279 
used as a method of reducing the metabolic rate of muscle preparations, subsequently 280 
maintaining its functional capacity for a longer duration. Mammals regulate core body 281 
temperature such that daily variation is less than 3oC in order to maintain homeostatic 282 
conditions (Refinetti 1999; Wooden and Walsberg 2004). Although there is some 283 
variation in peripheral muscle temperature as a result of ambient conditions and 284 
exercise, the relationship between higher skeletal muscle temperature within a 285 
physiological range and improved mechanical performance has been well documented 286 
(James et al., 2013). It should further be considered that studies using amphibian or 287 
insect muscle (Ritchie, 1954; Luttgau & Oetliker 1968; Huddart, 1969; Rosser et al., 288 
2009) may evoke different caffeine response when compared to mammalian muscle. 289 
 290 
Evidence in this area, bar the work of James and Tallis, has been gained via isometric 291 
testing methods, which although provide important information for assessing the 292 
effect of caffeine on maximal force, have poor relevance to in vivo power producing 293 
muscles (Josephson, 1985; James et al., 1995; James et al., 1996). It is rare for 294 
skeletal muscle to be acting completely isometrically with shortening required to 295 
perform work and to produce power (Rome, 2002). James et al., (1996) concluded 296 
that isometric testing vastly underestimated the in vivo rate of force activation and 297 
relaxation and is limited by not considering the passive properties of muscle. A 298 
muscle cannot shorten indefinitely and will eventually have to re-lengthen. In 299 
addition, locomotion is primarily determined by the ability of certain muscles to 300 
produce power (force x velocity), which cannot be estimated via isometric testing 301 
(James et al., 1995; 1996). 302 
 303 
Recent work by Tallis and James (James et al., 2004; 2005; Tallis et al., 2012; 2013b; 304 
2014a) has addressed these limitations and provides a more accurate assessment of the 305 
direct ergogenic effect of caffeine on skeletal muscle that can be more closely related 306 
to human performance. In this body of work, caffeine induced changes in muscle 307 
power output were quantified using the work loop method as a more realistic 308 
estimation of in vivo muscle function during power production (Josephson, 1985, 309 
James et al., 1995; 1996). As for in vivo power producing muscles, the work loop 310 
technique considers muscle force production over dynamic contractions accounting 311 
for the interaction of force production during shortening, resistance to muscle re-312 
lengthening and changes in activation and relaxation time using length change 313 
waveforms and stimulation parameters that more closely replicate those used in vivo 314 
(Josephson, 1985; James et al., 1995; 1996). More significantly, these studies 315 
examine the skeletal muscle response to 70 micromolar (µM) caffeine treatment that 316 
represents the likely normal in vivo human maximum (Graham, 2001) and is 317 
markedly lower than millimolar caffeine concentrations used in previous works. In 318 
addition, experiments are carried out on whole mammalian locomotory skeletal 319 
muscle at physiologically relevant test temperatures. 320 
 321 
 322 
The Effect of µM Concentrations of Caffeine on Skeletal Muscle Contractility 323 
 324 
James et al., (2004) was the first to examine the direct effect of 70µM caffeine on the 325 
mechanical performance of skeletal muscle, reporting no effect on force, work, or 326 
power output in fatigued EDL or soleus muscles. In contrast 10mM caffeine treatment 327 
evoked greater recovery of fatigued EDL, but a reduction in power output in fatigued 328 
soleus, and as such it was considered that caffeine, including when used in human 329 
performance, may not significantly affect the contractile performance of fatigued 330 
skeletal muscle. The aetiology of skeletal muscle fatigue is complex and a number of 331 
interacting mechanisms including a reduction in: SR Ca2+ release; sensitivity of the 332 
contractile proteins to Ca2+; and SR Ca2+ pump function (Allen et al., 2008). The 333 
results presented by James et al., (2004) infer that the potential effect of a 334 
physiologically relevant caffeine concentration to elicit modulation of calcium 335 
handling is not great enough to offset the changes brought about by fatiguing 336 
contractions. 337 
 338 
Additional work by James et al., (2005) was the first study to demonstrate a direct 339 
ergogenic effect of 70µM caffeine, reporting a small, but significant, 2-3% increase in 340 
the power output of non-fatigued mouse EDL muscle. This effect on EDL was later 341 
confirmed by Tallis et al., (2012), who also demonstrated a larger, 6%, increase in 342 
mouse soleus power output, uniquely highlighting a fiber type specific effect at 343 
physiological doses. Although not directly measured, this increase in power output 344 
was attributed to a caffeine induced increase in Ca2+ release resulting in an increased 345 
ability of the muscle to produce work when electrically stimulated during shortening 346 
and a greater production of net work, as indicated via analysis of the work loop shape 347 
(Fig 2). The area encompassed by the work loop represents the net work done (see Fig 348 
2) and this is calculated by subtracting the negative work (energy input required to 349 
lengthen the muscle) from the positive (work output during shortening). Figure 2 350 
demonstrates that when treated with caffeine the muscles produced greater force 351 
during shortening, than the control, leading to an increase in net work and power 352 
output. The demonstrated response outlined by Tallis et al., (2012) may infer an 353 
amplified ergogenic effect of caffeine during prolonged submaximal activities that 354 
have a greater reliance on more oxidative fiber types.   355 
 356 
[Insert Figure 2 here] 357 
 358 
Tallis et al., (2012) further demonstrated that the ergogenic benefit of caffeine was of 359 
similar magnitude at both maximal and submaximal activation intensities. This is 360 
particularly interesting as evidence using millimolar concentrations of caffeine 361 
suggests that the caffeine induced potentiation of twitch force is greater than that in 362 
tetani (Wondmikun et al., 2006). Theoretically, during submaximal stimulation there 363 
is a larger pool of Ca2+ in the SR which could allow a greater release in the presence 364 
of caffeine resulting in greater force production. In light of these results it is 365 
considered that the mechanism by which caffeine acts directly at the muscle may be 366 
more complex than first thought and that the caffeine-induced release of Ca2+ is in 367 
some way limited. This warrants further investigation, using physiological doses, of 368 
the direct mechanism of the action of caffeine.  369 
 370 
The findings by Tallis et al., (2012) are the first to demonstrate no caffeine related 371 
dose-response relationship when physiologically relevant concentrations are used 372 
directly on the muscle, similar to previous findings in a large proportion of the in vivo 373 
human performance literature (Pasman et al., 1995; Graham & Spriet, 1995; Bruce et 374 
al., 2000; O’Connor et al., 2004). In fact the findings of Tallis et al., (2012) 375 
demonstrate an ‘all or none’ relationship, whereby treatment will either cause the 376 
potentiation of force or there is a lack of response. Consequently, it is considered that 377 
much higher concentrations of caffeine are needed to promote a dose response effect 378 
as reported by Fryer and Neering (1989), and as such there is little human relevance 379 
of such work. Interestingly, the results of Tallis et al., (2012) indicate that the direct 380 
ergogenic benefit of caffeine can be achieved using only 50µM, making it increasing 381 
likely that direct caffeine induced improvements in the mechanical performance of 382 
skeletal muscle contribute to the ergogenic benefit demonstrated in vivo.  383 
 384 
An inter-individual variation in the magnitude of response and a division of 385 
responders and non-responders has been reported in the human literature (Skinner et 386 
al., 2009; Astorino, 2011). Recent in vitro studies have also demonstrated contrasting 387 
responses to caffeine between muscles isolated from different individuals (James et 388 
al., 2005; Tallis et al., 2012). This is particularly interesting as previously this varied 389 
response has been attributed habituation to the caffeine response due to regular 390 
exposure. As the rodents used in this study do not consume a high caffeine diet, this 391 
confirms further mechanisms are responsible for this effect. 392 
 393 
James et al., (2005) and Tallis et al., (2013b) were also the first to measure the effect 394 
of physiologically relevant caffeine treatment on the ability of the muscle to sustain 395 
power output. 70µM caffeine had no effect on maximally fatigued EDL (James et al., 396 
2005), but time to fatigue was significantly increased in maximally fatigued (by 17.6 397 
%) and prolonged in submaximally fatigued (by 19.2%) soleus muscle (Tallis et al., 398 
2013b). Indirectly these results confirm the action of physiologically relevant 399 
concentrations of caffeine as a modulator of excitation contraction coupling which 400 
can be seen by examining the work loop shapes generated in these studies (Fig 3). 401 
Here work loops shapes 0.4s, 2.4s, 4.8s, and 7.2s from the start of the fatiguing 402 
protocol are plotted for control and caffeine treated conditions and a further 403 
comparison between maximal and submaximal stimulation is made. In all examples 404 
the area of the work loop becomes smaller over time as the ability of the muscle to 405 
produce work is reduced. Interestingly, in the maximally stimulated protocol, the 406 
caffeine treated muscle produced greater force during the re-lengthening phase post 407 
active shortening when compared to controls (as indicated in Fig 3a&b), which will 408 
greatly influence the net work achieved. The net work produced is the sum of the 409 
work generated during shortening minus the work required to lengthen the muscle. If 410 
the muscle is active to a greater degree while it is being elongated, the energy required 411 
to stretch the muscle is increased, thus reducing the net work. The outlined decrease 412 
in time to fatigue was attributed to a caffeine induced increase in basal intramuscular 413 
Ca2+ concentration and reduced activity of the SR Ca2+ pump (Allen et al., 1989; 414 
Westerblad & Allen, 1991; Allen & Westerblad, 1995) causing a more exaggerated 415 
slowing of relaxation throughout the fatiguing protocol. In support of this it was 416 
further reported that the ability of the caffeine treated muscles to recover was 417 
significantly reduced indicating damage from the fatigue run, attributed to a caffeine 418 
evoked increase in high intensity eccentric activity.  419 
 420 
[Insert Figure 3 here] 421 
 422 
It is important that the effects of caffeine on acute power and on the fatigue response, 423 
as reported by James et al., (2005) and Tallis et al., (2012), are not viewed in 424 
isolation. In these studies the muscle is treated with caffeine and then the decline in 425 
peak muscle power output as a percentage of this maximal (100%) is plotted over 426 
time, thus masking any acute effect of the treatment. More simply, if EDL muscle is 427 
able to produce 3% more power but fatigues at the same rate as controls (James et al., 428 
2005), a positive caffeine induced fatigue response is realised. A review of this work 429 
has presented a number of novel findings which may highlight the significance of the 430 
skeletal muscle response in caffeine induced improvements during human sports 431 
performance.  432 
 433 
Applications to Human Performance 434 
 435 
The evidence presented infers that physiological concentrations of caffeine can 436 
directly affect skeletal muscle to cause a significant enhancement in mechanical 437 
performance increasing the ability of the muscle to produce force, work and power. 438 
Although the 3% and 6 % improvements in power output for fast and slow twitch 439 
muscle respectively (Tallis et al., 2012) may seem small, these gains could prove 440 
meaningful in competitive performance, that at elite level is decided by narrow 441 
margins, or as an effective training aid promoting an amplified training stimulus. The 442 
demonstrated fiber type specific effect (Fryer & Neering, 1989; Germinario et al., 443 
2004; Tallis et al., 2012) indicates an amplified ergogenic benefit during prolonged 444 
submaximal activities that have a greater reliance on oxidative fibers, providing 445 
further evidence supporting the increased potency of caffeine in endurance based 446 
activities. 447 
 448 
Interpretation of the possible benefit of caffeine during fatiguing exercise is complex, 449 
but if muscle is able to produce a greater maximal power in vivo, the desired muscle 450 
power output may be achieved with a smaller number of recruited fibres, thus 451 
delaying the recruitment of further fibres and potentially the fatigue response. 452 
Alternatively, during human performance it may be possible to produce a greater 453 
maximal power output, but a similar fatigue response following caffeine treatment 454 
(James et al., 2005), enabling a faster performance time. 455 
 456 
The work loop method is a valuable tool for assessing the mechanical performance of 457 
skeletal muscle, however it should be noted that the length change wave forms and 458 
stimulation patterns used in vitro are simplified approximations of what may occur in 459 
vivo. In vivo the patterns of fiber stimulation and length change waveforms are likely 460 
to be manipulated throughout movement in order to maximise muscle economy and 461 
prevent the onset of fatigue (Wakeling, 2005). This may be particularly true when it 462 
comes to fatiguing stimulation, as it is likely that activation and length change 463 
patterns will be modified to prevent the muscle damage seen in some of the in vitro 464 
caffeine treated muscle (Tallis et al., 2013b). With consideration of these limitations, 465 
it may be that the magnitude of the direct effect of caffeine on isolated skeletal muscle 466 
during fatiguing activities is greater than that portrayed in this review. 467 
 468 
Although the current review presents substantial evidence demonstrating the ability of 469 
caffeine to cause significant improvements in muscle contractility, this may be one of 470 
only a number of mechanisms that works synergistically to promote the performance 471 
enhancing effect seen in humans. Most noteworthy is the action of caffeine as a 472 
central adenosine receptor antagonist, particularly on A1 and A2a receptors, 473 
promoting an elevated release of neurotransmitters due to withdrawal of the adenosine 474 
effect (Garrett & Griffiths, 1997; Fredholm, 1999; Ribeiro & Sebastião, 2010). A 475 
primary central mechanism of caffeine is to prevent the adenosine induced 476 
suppression of dopamine release (Okada et al., 1997; Davis et al., 2003), contributing 477 
to the commonly reported increase alertness and arousal (Nehlig, 2010). Evidence 478 
further suggests that caffeine may modify CNS function by inhibiting 479 
phosphodiesterase activity resulting in elevated cAMP, blocking GABAA receptors 480 
and mobilising intracellular calcium, although it is considered that the dose required 481 
to promote such effects is greater than that necessary to block adenosine receptors 482 
(Garrett & Griffiths, 1997; Davis et al., 2003). Due to the interaction of these 483 
mechanisms it is likely that the effect of caffeine in whole body human performance 484 
may is greater than that portrayed in this review alone. 485 
 486 
Furthermore the interaction of caffeine with adenosine receptors has been shown to 487 
stimulate lipolysis (Garrett & Griffiths, 1997), however the literature is rife with 488 
evidence demonstrating performance enhancing effects of caffeine in the absence of 489 
increased plasma FFA’s, changes in RER, and the popularised glycogen sparing 490 
mechanism (see review by Graham, 2001).  Moreover this mechanism would not 491 
contribute to the performance enhancing effect of caffeine demonstrated in short term 492 
anaerobic events.   493 
 494 
The freely available and socially acceptable nature of caffeine consumption within 495 
society, and the issues with accurately measuring consumption form the primary 496 
rationale for its removal for the World Anti-Doping Agency (WADA) prohibited list. 497 
With the demonstrated magnitude of its effects, and the seemingly unpredictable 498 
division of responders and non-responders to the drug, it is conceivable that 499 
individuals could elicit a significant legal enhancement in performance that may not 500 
be comparable in all competitors.   501 
 502 
The majority of research evaluating the ergogenic effects of caffeine has been 503 
conducted on subjects within the range of physiological maturity. With the associated 504 
age related changes in muscle fiber type composition and reduced efficiency of the 505 
excitation-contraction coupling process (Deschenes, 2004; Tallis et al., 2014b), it is 506 
conceivable that the ergogenic benefit of caffeine may differ in children and older 507 
populations. Work by our research group has indicated that direct 70µM caffeine still 508 
adequately produces significant increases in muscle power across a wide age range of 509 
mice, however the effectiveness of the treatment is reduced with increasing age 510 
(Tallis, 2013a). Although a comparably under researched area, support for the 511 
ergogenic effect of caffeine in older adults has been demonstrated in human 512 
performance literature (Norager et al., 2005; Duncan et al., 2014).  513 
 514 
Conclusion 515 
 516 
This review considers the contribution of evidence from isolated muscle studies to our 517 
understating of the direct effects of caffeine on muscle during human performance. 518 
The body of in vitro evidence presented suggests that caffeine can directly potentiate 519 
skeletal muscle force, work and power which may well contribute to the overall 520 
performance enhancing effects seen in humans. The established fibre type specific 521 
effect adds clarity to the demonstrated increased potency of caffeine when used to 522 
promote enhancements in endurance activities. Interestingly, the evidence from in 523 
vitro studies demonstrates a division between responders and non-responders to 524 
caffeine treatment that cannot be attributed to habituation or inter-individual 525 
differences in digestion and distribution. Importantly it is considered that future in 526 
vitro experimental design and interpretation is improved to more accurately replicate 527 
physiological conditions in humans, if it is the intention of such studies to relate their 528 
results to potential changes in human performance.  529 
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Figures 945 
 946 
Figure 1 – Variables that Limit our Ability to Compare Between Research Studies 947 
Examining the Ergogenic Effects of Caffeine in vitro 948 
 949 
 950 
Figure 2 - Typical effects of caffeine treatment on work loop shapes in mouse EDL 951 
(left) and soleus (right) stimulated maximally at 5-Hz cycle frequency. Solid loops, 952 
control; dashed loops, caffeine treated (Tallis et al., 2012). Each work loop cycle 953 
started at length 0 (optimal length for producing isometric force). Each muscle was 954 
lengthened by 5% of its resting length and electrically stimulated to produce force. 955 
Each muscle was stimulated to produce force during shortening.  Near to the end of 956 
shortening, the electrical stimulation ceased and the muscle was lengthened back to 957 
the initial length, 0). The area inside the loop represents the net work done (active 958 
work – passive work).   959 
 960 
 961 
Figure 3- Typical effects of fatigue on work loop shape for maximally and 962 
submaximally stimulated mouse soleus muscle (A 140Hz stimulation frequency & C 963 
40Hz stimulation frequency respectively) compared with those treated with 70µM 964 
caffeine (B 140Hz, caffeine and D 40Hz, caffeine) [Arrows indicate where stimulation 965 
typically started, towards the end of lengthening, and finished, during shortening; 966 
0.4s, 2.4s, 4.8s, & 7.2s represent time since the start of the fatigue protocol for each 967 
of the work loops shown] (Tallis et al., 2013). 968 
